Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Clinical trial NCT00865098 · COMPLETED
Trial details
- NCT number
- NCT00865098
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-06-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.